HUTCHMED (China) (HMDCF) Shareholder's Equity (2014 - 2025)

HUTCHMED (China) (HMDCF) Shareholder's Equity (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.23 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.75 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 446.17 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.21 Bn
10 HUTCHMED (China) - - - 1.25 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Bn
Jun 30, 2025 1.24 Bn
Jun 30, 2024 752.02 Mn
Jun 30, 2023 800.02 Mn
Dec 31, 2022 636.87 Mn
Jun 30, 2022 851.85 Mn
Dec 31, 2021 1.04 Bn
Jun 30, 2021 1.01 Bn
Mar 31, 2021 464.40 Mn
Dec 31, 2020 518.95 Mn
Jun 30, 2020 367.05 Mn
Dec 31, 2019 312.90 Mn
Dec 31, 2018 411.58 Mn
Dec 31, 2017 483.88 Mn
Jun 30, 2017 211.50 Mn
Dec 31, 2016 204.06 Mn
Jun 30, 2016 199.17 Mn
Dec 31, 2015 102.28 Mn
Dec 31, 2014 56.92 Mn